FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150906543> ?p ?o ?g. }

• W2150906543 endingPage "237" @default.
• W2150906543 startingPage "220" @default.
• W2150906543 abstract "Long-acting β2-agonists (LABAs) have been shown to be effective first-line bronchodilators in the treatment of COPD patients, and inhaled corticosteroids (ICSs) have been shown to reduce the frequency and/or severity of exacerbations in COPD patients. The concomitant use of a LABA and an ICS can influence both airway obstruction (ie, smooth muscle contraction, increased cholinergic tone, and loss of elastic recoil), and airway inflammation (ie, increased numbers of neutrophils, macrophages, and CD8+ lymphocytes, elevated interleukin-8 and tumor necrosis factor-α levels, and protease/antiprotease imbalance). They are also able to reduce the total number of bacteria adhering to the respiratory mucosa in a concentration-dependent manner without altering the bacterial tropism for mucosa, and to preserve ciliated cells. Several clinical trials support the concept of inhaled combination therapy with LABAs and corticosteroids in stable COPD patients. This type of therapy not only improves airflow obstruction but also provides clinical benefits, as manifested by sustained reduction in overall symptoms, improvements in health-related quality of life, and reductions in exacerbations. All of these effects are very important because, despite recent advances in our understanding of COPD and its treatment, therapy remains suboptimal for a considerable number of patients. Long-acting β2-agonists (LABAs) have been shown to be effective first-line bronchodilators in the treatment of COPD patients, and inhaled corticosteroids (ICSs) have been shown to reduce the frequency and/or severity of exacerbations in COPD patients. The concomitant use of a LABA and an ICS can influence both airway obstruction (ie, smooth muscle contraction, increased cholinergic tone, and loss of elastic recoil), and airway inflammation (ie, increased numbers of neutrophils, macrophages, and CD8+ lymphocytes, elevated interleukin-8 and tumor necrosis factor-α levels, and protease/antiprotease imbalance). They are also able to reduce the total number of bacteria adhering to the respiratory mucosa in a concentration-dependent manner without altering the bacterial tropism for mucosa, and to preserve ciliated cells. Several clinical trials support the concept of inhaled combination therapy with LABAs and corticosteroids in stable COPD patients. This type of therapy not only improves airflow obstruction but also provides clinical benefits, as manifested by sustained reduction in overall symptoms, improvements in health-related quality of life, and reductions in exacerbations. All of these effects are very important because, despite recent advances in our understanding of COPD and its treatment, therapy remains suboptimal for a considerable number of patients." @default.
• W2150906543 created "2016-06-24" @default.
• W2150906543 creator A5020135918 @default.
• W2150906543 creator A5060089859 @default.
• W2150906543 date "2004-07-01" @default.
• W2150906543 modified "2023-09-26" @default.
• W2150906543 title "Inhaled Combination Therapy With Long-Acting β 2 -Agonists and Corticosteroids in Stable COPD" @default.
• W2150906543 cites W1692839365 @default.
• W2150906543 cites W1850996803 @default.
• W2150906543 cites W1892949664 @default.
• W2150906543 cites W1913560365 @default.
• W2150906543 cites W1969820627 @default.
• W2150906543 cites W1972692051 @default.
• W2150906543 cites W1973651993 @default.
• W2150906543 cites W1977176665 @default.
• W2150906543 cites W1977496327 @default.
• W2150906543 cites W1980796070 @default.
• W2150906543 cites W1982193727 @default.
• W2150906543 cites W1987062528 @default.
• W2150906543 cites W1989448936 @default.
• W2150906543 cites W1989738601 @default.
• W2150906543 cites W1989877439 @default.
• W2150906543 cites W1991498703 @default.
• W2150906543 cites W1991648511 @default.
• W2150906543 cites W1991929005 @default.
• W2150906543 cites W1992325315 @default.
• W2150906543 cites W1995257163 @default.
• W2150906543 cites W2002796983 @default.
• W2150906543 cites W2002899996 @default.
• W2150906543 cites W2006193143 @default.
• W2150906543 cites W2009343792 @default.
• W2150906543 cites W2009453368 @default.
• W2150906543 cites W2011707286 @default.
• W2150906543 cites W2012078431 @default.
• W2150906543 cites W2025564699 @default.
• W2150906543 cites W2030453913 @default.
• W2150906543 cites W2030601160 @default.
• W2150906543 cites W2039783150 @default.
• W2150906543 cites W2041105963 @default.
• W2150906543 cites W2045616259 @default.
• W2150906543 cites W2049197899 @default.
• W2150906543 cites W2052893447 @default.
• W2150906543 cites W2065804207 @default.
• W2150906543 cites W2068045085 @default.
• W2150906543 cites W2079029414 @default.
• W2150906543 cites W2079777289 @default.
• W2150906543 cites W2081180334 @default.
• W2150906543 cites W2081906045 @default.
• W2150906543 cites W2085467958 @default.
• W2150906543 cites W2088022718 @default.
• W2150906543 cites W2088520852 @default.
• W2150906543 cites W2093763580 @default.
• W2150906543 cites W2094774911 @default.
• W2150906543 cites W2095955239 @default.
• W2150906543 cites W2097483036 @default.
• W2150906543 cites W2099269522 @default.
• W2150906543 cites W2109593534 @default.
• W2150906543 cites W2109921129 @default.
• W2150906543 cites W2113707806 @default.
• W2150906543 cites W2114742328 @default.
• W2150906543 cites W2117836526 @default.
• W2150906543 cites W2120629366 @default.
• W2150906543 cites W2123709617 @default.
• W2150906543 cites W2124006946 @default.
• W2150906543 cites W2126648631 @default.
• W2150906543 cites W2126675070 @default.
• W2150906543 cites W2132084781 @default.
• W2150906543 cites W2133119676 @default.
• W2150906543 cites W2135070639 @default.
• W2150906543 cites W2137576594 @default.
• W2150906543 cites W2139297598 @default.
• W2150906543 cites W2139659037 @default.
• W2150906543 cites W2139666950 @default.
• W2150906543 cites W2144343902 @default.
• W2150906543 cites W2145152803 @default.
• W2150906543 cites W2146645666 @default.
• W2150906543 cites W2152194899 @default.
• W2150906543 cites W2153571482 @default.
• W2150906543 cites W2166084959 @default.
• W2150906543 cites W2166505581 @default.
• W2150906543 cites W2167089458 @default.
• W2150906543 cites W2167682972 @default.
• W2150906543 cites W2171964415 @default.
• W2150906543 cites W2268275976 @default.
• W2150906543 cites W2322866941 @default.
• W2150906543 cites W2331287401 @default.
• W2150906543 cites W2416409095 @default.
• W2150906543 cites W2468637518 @default.
• W2150906543 cites W26691815 @default.
• W2150906543 cites W2781279492 @default.
• W2150906543 cites W4292166591 @default.
• W2150906543 cites W52826647 @default.
• W2150906543 doi "https://doi.org/10.1378/chest.126.1.220" @default.
• W2150906543 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15249466" @default.
• W2150906543 hasPublicationYear "2004" @default.
• W2150906543 type Work @default.
• W2150906543 sameAs 2150906543 @default.
• W2150906543 citedByCount "78" @default.

• next